Australia/Canberra: Vy & Tea Australia, a Melbourne, Victoria establishment, recalls certain batch/lots of Havyco Vy & Tea products from the Australian marketplace due to undeclared Phenolphthalein and Sibutramine with consequential elevated risks of cardiac events as well as increased risks of certain types of Cancers, all serious health and safety hazards requiring immediate medical intervention to minimize pain and suffering as well as prevent life-altering injury or death.
ACCC: http://ht.ly/83b030sfJnW
Direct link: https://www.productsafety.gov.au/recalls/vy-tea-australia-%E2%80%94-havyco-vy-tea-45g
Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following Dietary Supplement Tea products are subject to this recall:
Filed under: ACCC, Carcinogen (Cancer-causing), Dietary Supplements, Drugs, Labeling or regulatory issues, Phenolphthalein, Sibutramine | Tagged: ACCC, ACCC PRA number: 2022/19421, Australian Competition & Consumer Commission, Cancer, carcinogenic hazard, cardiac arrest hazard, dietary supplement, Dietary Supplement Tea products, drug, Havyco, Havyco Vy & Tea, medication, Nutritional Supplements, Recalls Direct RIN: 15626-2022, respiratory arrest hazard, supplement, tea, Vy & Tea Australia | Leave a comment »